Coronavirus Live Count Map India
remove_red_eye 826 Views
COVID-19 Vaccine Updates
#Gastroenterology #Pathology and Lab Medicine #Pharmacist #Public Health
The US Food and Drug Administration (FDA) has approved oral ferric maltol (Accrufer, Shield Therapeutics) for the treatment of iron deficiency in adults.
The product is already approved in the European Union and Switzerland for the treatment of iron deficiency in adults, where it is sold as Feraccru.
Ferric maltol, a nonsalt formulation of ferric iron, provides an alternative to salt-based oral iron therapies, with fewer of the gastrointestinal side effects typically observed with salt-based therapies, the company said... (Medscape)